Sunday, May 24, 2020
politiko-politics-ph-logo

Strike Revilla wants more diseases covered by mandatory immunization program for kids

Aug 29, 2019 @ 20:16

Cavite Rep. Strike Revilla wants the coverage of the government’s mandatory immunization program for children expanded to include more diseases.

Revilla filed House Bill 437 to ensure the health of infants and children as parents become wary of immunization due to the controversy over the Dengvaxia vaccine.

The bill, which seeks to amend Republic Act 19152 or the Mandatory Infants and Children Health Immunization Act of 2011, proposes to include the following diseases in the coverage of the government’s mandatory vaccination program: tuberculosis; diphtheria, tetanus and pertussis; poliomyelitis; measles; mumps; rubella (German measles); hepatitis B; H influenza type B; Rota virus; Japanese encephalitis; pneumococcal conjugate vaccine; human papilloma virus, and hepatitis C.

HB 437 also transfers the power to include vaccine-preventable diseases not in the law’s coverage to Congress instead of the Health Secretary.

Revilla said the Dengvaxia controversy was a reminder for everyone “not to put in an individual’s wisdom the responsibility of deciding the fortune of many innocent infants and children.”

Dengvaxia was shown to have increased the risk of individuals contracting severe dengue if they were inoculated with it when they did not have the viral disease.

The Department of Health, under then-Health Secretary Janette Garin, procured the vaccine in bulk from French manufacturer Sanofi Pasteur for a mass vaccinationn program in 2015.

The controversy over the vaccine prompted the Food and Drug Authority to revoke Dengvaxia’s license.

Politiko would love to hear your views on this...
Disclaimer:
The comments posted on this site do not necessarily represent or reflect the views of management and owner of POLITICS.com.ph. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

Trending News

Want Politiko alerts on your inbox? Subscribe here.